Quercetin shows genuine promise for arthritis, particularly rheumatoid arthritis, though the evidence is still early. In the best clinical trial to date, women with rheumatoid arthritis who took 500 mg of quercetin daily for eight weeks experienced significant improvements in pain, disease activity, and physical function compared to a placebo group. The science behind these results is solid: quercetin targets several of the same inflammatory pathways that drive joint damage in both rheumatoid and osteoarthritis. But there are important caveats about how well your body actually absorbs it and how much difference it can make on its own.
How Quercetin Works Against Joint Inflammation
Arthritis, whether rheumatoid or osteoarthritis, is driven by chronic inflammation in and around the joints. Your immune system produces a cascade of inflammatory molecules that break down cartilage, cause swelling, and trigger pain. Quercetin interrupts this process at multiple points.
It lowers levels of several key inflammatory molecules, including TNF-alpha, IL-6, IL-1 beta, and IL-17, all of which play central roles in joint destruction. It also blocks COX-2, the same enzyme targeted by anti-inflammatory drugs like ibuprofen, which reduces production of pain-triggering prostaglandins. Beyond that, quercetin suppresses NF-kB, a master switch inside cells that turns on dozens of inflammatory genes at once. Animal studies in arthritic mice have confirmed that quercetin reduces both TNF-alpha and IL-17 in joint tissue specifically.
It also inhibits enzymes called matrix metalloproteinases that physically break down cartilage. This combination of anti-inflammatory and cartilage-protective effects is what makes quercetin particularly interesting for arthritis rather than just general inflammation.
Evidence for Rheumatoid Arthritis
The strongest human evidence comes from a double-blind, randomized controlled trial published in the Journal of the American College of Nutrition. Fifty women with rheumatoid arthritis were split into two groups: one received 500 mg of quercetin per day, the other a placebo. After eight weeks, the quercetin group showed significant improvements in clinical symptoms, disease activity scores, and scores on a disability questionnaire that measures how well people can perform daily tasks like dressing, eating, and walking.
The trial also measured TNF-alpha in the blood and found a significant reduction in the quercetin group. This is notable because TNF-alpha is the exact molecule targeted by some of the most powerful (and expensive) rheumatoid arthritis drugs on the market. Quercetin won’t replace those medications, but the fact that it measurably lowers the same inflammatory marker suggests it could be a useful complement to standard treatment.
One limitation: this was a relatively small trial with only 50 participants, all women. Larger studies with more diverse populations are needed to confirm these findings.
What About Osteoarthritis?
The picture for osteoarthritis is less clear. While quercetin’s anti-inflammatory and cartilage-protective mechanisms are relevant to osteoarthritis, there are fewer human trials focused specifically on this form. Most of the osteoarthritis evidence comes from lab and animal studies showing that quercetin protects cartilage cells from breaking down and reduces inflammatory signaling in joint tissue.
A large network meta-analysis of botanical extracts for knee osteoarthritis, published in Frontiers in Pharmacology in 2025, evaluated many plant-based compounds but did not single out quercetin as a top performer for pain or physical function scores. This doesn’t mean it’s ineffective, but it does mean the clinical data for osteoarthritis isn’t as compelling as what exists for rheumatoid arthritis.
Quercetin Lowers C-Reactive Protein
C-reactive protein (CRP) is one of the most commonly used blood markers for systemic inflammation, and elevated CRP is a hallmark of active arthritis. A meta-analysis of seven randomized controlled trials found that quercetin supplementation significantly reduced CRP levels by an average of 0.33 mg/L. That reduction was most consistent in studies using doses of 500 mg per day or higher.
For context, CRP levels above 3 mg/L are generally considered elevated and associated with higher cardiovascular and inflammatory risk. A drop of 0.33 mg/L is modest but meaningful, particularly as part of a broader anti-inflammatory approach. Interestingly, the strongest CRP-lowering effect appeared in people whose levels were already below 3 mg/L, suggesting quercetin may be better at keeping low-grade inflammation in check than at reversing highly active disease.
The Absorption Problem
Here’s the catch: standard quercetin powder is poorly absorbed. In a pharmacokinetic study comparing different formulations, volunteers who took 500 mg of regular quercetin barely reached blood levels of 11 ng/mL. That’s a very low concentration, and it raises questions about whether the quercetin from a standard supplement actually reaches your joints in meaningful amounts.
A formulation called quercetin phytosome, which combines quercetin with lecithin (a natural fat found in egg yolks and soybeans), dramatically improves absorption. The same study found that 500 mg of the phytosome version produced peak blood levels of about 223 ng/mL, roughly 20 times higher than regular quercetin at the same dose. Even a 250 mg dose of the phytosome form outperformed 500 mg of the standard powder by a wide margin.
This matters practically. If you’re considering quercetin for arthritis, the form you choose could be the difference between getting enough into your bloodstream to have an effect and essentially wasting your money. Look for products labeled as quercetin phytosome or those that specifically mention enhanced bioavailability through a lecithin-based delivery system.
Dosage Used in Trials
The clinical trial showing benefits for rheumatoid arthritis used 500 mg per day, taken over eight weeks. The CRP meta-analysis also found that doses of 500 mg or more were needed to produce a statistically significant reduction in inflammation markers. Lower doses have not been reliably tested for arthritis outcomes.
If you’re using a phytosome formulation, 250 mg may deliver comparable blood levels to 500 mg of standard quercetin, based on the absorption data. But since the clinical trials that demonstrated joint benefits used 500 mg of a standard form, it’s not yet clear whether a lower dose of a better-absorbed form would produce the same results.
Safety and Side Effects
Quercetin has a strong safety profile. A meta-analysis of clinical trials found it was well tolerated with no serious adverse events reported. The most common complaints are mild: occasional abdominal discomfort, nausea, or headache, occurring at rates similar to placebo.
Liver safety is not a concern based on current data. The NIH’s LiverTox database rates quercetin as an “unlikely cause of clinically apparent liver injury,” noting that no published cases of liver damage have been attributed to it. No kidney-related adverse effects have been reported either.
The main area of uncertainty is drug interactions. Germany’s Federal Institute for Risk Assessment has noted that there isn’t enough data on how quercetin interacts with medications in humans. Because quercetin can affect how the body processes certain drugs, particularly those metabolized by the same liver enzymes, people taking blood thinners, immunosuppressants, or other medications for arthritis should discuss quercetin with their prescribing doctor before adding it.
Quercetin in Food vs. Supplements
Quercetin occurs naturally in onions, apples, berries, capers, broccoli, and green tea. A typical Western diet provides somewhere between 10 and 100 mg per day, depending on how many fruits and vegetables you eat. That’s well below the 500 mg dose used in arthritis trials, which is why supplementation is necessary to reach potentially therapeutic levels.
Eating quercetin-rich foods still contributes to your overall anti-inflammatory intake and provides other beneficial compounds. But if you’re specifically trying to address arthritis symptoms, food sources alone won’t get you to the doses that have shown results in clinical trials.